So you talked about two important, use cases. And this is something that happens so much clinically. I mean, you have been an ED physician all the time. I've been an ICU stroke physicians. And believe it or not, when you are implementing it in a multi-site system, let's say if I'm sitting here at a quaternary center with director of data, ICU director of stroke, there is actually a hundred bed hospital. This is now primary care stroke center. And over there, even the physicians, not just nurse practitioners or PAs, have very low experience. mean, they actually see two stroke patients a month max as compared to me seeing literally 300 stroke patients a month. So the idea is that you're absolutely right that when we have to do this, we have to start with, you know, clinical dialogue without medical advice. So this is something that we actually see that. And then you can see that it can actually go into these agents. So, PCP and DA are actually making their SOAP note while, more importantly, there's a guardrail agent that is consistently taking this collection. And then they see over that. And then what they do is that within that SOAP note, there is a clinical cockpit. And the cockpit, again, looks exactly like what we're talking about. The clinician cockpit is that there's a dial-up transcript, subjective analysis assessment, patient message follow-up, and then they select A and B. Again, what they are doing is a second guardrail. That second guardrail is essentially a human in loop. There is HIP. that's another, there are different terms that people have used. Again, there are people who use different terms as well. So the idea is that we actually go ahead and look at this into a performative way that GAMI outperforms general PCPs and general MPs. So they compare this into the system. And what they realize is that you know, they were this particular guardrail system with asynchronous oversight is amazing in terms of implementation as far as in real world is concerned. So that is exactly what Dr. Castro was saying that how we should know that SOAP notes and asynchronous oversight is concerned. One of the key ways that this guardrail was done, again, we don't want to go into too much detail. They actually have I just want to make sure dialogue phase transition. So they have done at every phase, generate response, response, and then there's medical advice. If there is medical advice, device through the human in loop system. So I love this system, honestly. I think there's three different approaches. So let's just talk about the second approach that is done by, so this was Google's approach. Now let's just go talk about OpenAI's approach. So this is interesting that again, as I said, people have different approaches on how they have done. So this is the AI-based clinical decision support. Same thing, but they have restricted to primary care. And again, we discussed this in one of those meetings, one of the ideas. So this is their system as well. What they have done it is AI-based clinical decision support. And this is the real-world study, by the way. And they have done it for 22,000 clinical visits. Interesting. Yeah. So one of the things is like, when you look at this initial documentation, you know, blood loss, appearance, absent parasite, no, et cetera, crystals, metronidol supplement five, three times a day, contribute to AI consultant response. And they are saying that the treatment involves metronidol, which is not an indication for uncomplicated gastrointestinal interwrites. So this is exactly where AI consultant comes in. Now, this is really interesting and actually scary because what he's saying is that for primary care, what did they do? they actually added a GI consult and that GI consult is going to be a super special that is going to be available and that is going to say, you know what, you don't need metronidazole, you just need zinc and you just need ORS. That's it. Saving time, saving costs, saving potential risk side effects of the medication and most importantly, evaluating for this. And again, think of this particular thing is that you will not have problems with utilization review and getting reimbursement from the, you know, that is what is called from insurance agents. Okay. And this is the third approach. And the third approach is that that is from Microsoft. And they said that sequential diagnosis with large language models. And then they did, you know, a whole sort of medical orchestration. And what they did was that to improve, you know, overall output, decrease the hallucination. What they did was that they and their design technical framework was to make an orchestrator and then create multiple different agents below it. And then all of that agents are super specialized and have their own guardrail. And therefore, think of it that a pharmacist is there. Think of it as a occupational therapist is there while you're doing a PCP or a cardiologist or a neurologist. And the idea is that you have created multiple amazing agents. And this way you actually progressively take that input and then slowly combine that into one diagnostic. Well, again, this is only related to diagnosis rather than giving a complete sort of picture in terms of treatment and management, which is different from the open AI approach and of course, the Google approach again.